Cerenis Therapeutics' IPO

Cerenis Therapeutics raised a round of funding on March 26, 2015. Investors include Public.

Cerenis Therapeutics is a biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases. Cereni…

Articles about Cerenis Therapeutics' IPO: